IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—17 September 2013

3:40 AM MDT | September 17, 2013 | Deepti Ramesh

ICIG to acquire peptide APIs firm Peptisyntha from Solvay International Chemical Investors Group (ICIG), a privately owned industrial holding company, says that it has entered into an agreement with Solvay to acquire the latter's subsidiary Peptisyntha (Brussels), a custom manufacturer of peptides for pharmaceutical use. Financial details of the deal have not been disclosed. The transaction is expected to be completed this fall, and Peptisyntha will become a member of ICIG's CordenPharma platform as its third site offering peptides manufacturing. For Solvay, the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa